RhumbLine Advisers’s T2 Biosystems, Inc TTOO Stock Holding History

RhumbLine Advisers’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8	Closed	-$101K	–	3017
2019 Q1	$101K	Buy	8 +1	+14%	+$17K	﹤0.01%	2857
2018 Q4	$113K	Buy	7 +2	+40%	+$47K	﹤0.01%	2866
2018 Q3	$173K	Hold	5	–	–	﹤0.01%	2775
2018 Q2	$175K	Buy	+5	New	+$190K	﹤0.01%	2769
2017 Q2	–	Sell	-3	Closed	-$75K	–	2967
2017 Q1	$75K	Buy	3 +1	+50%	+$28.1K	﹤0.01%	2799
2016 Q4	$55K	Hold	2	–	–	﹤0.01%	2823
2016 Q3	$79K	Hold	2	–	–	﹤0.01%	2832
2016 Q2	$84K	Buy	+2	New	+$90.3K	﹤0.01%	2934

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RhumbLine Advisers's TTOO Position: Q2 2019 in Review

RhumbLine Advisers sold out of T2 Biosystems, Inc (TTOO) in Q2 2019, closing a stake of 8 shares — an estimated $101K sold.

RhumbLine Advisers first reported a position in TTOO in Q2 2016 and held it in 8 quarters. The position peaked at $175K in Q2 2018. 63 funds tracked by Wall St. Rank hold TTOO as of Q2 2019.

RhumbLine Advisers reported no remaining T2 Biosystems, Inc position as of Q2 2019 after selling out during the quarter.
RhumbLine Advisers sold 8 T2 Biosystems, Inc shares in Q2 2019, an estimated $101K.
RhumbLine Advisers first reported a position in T2 Biosystems, Inc in Q2 2016 and held it in 8 quarters.
RhumbLine Advisers's T2 Biosystems, Inc position peaked at $175K in Q2 2018.
63 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2019.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.